Publicación:
El síndrome de Lambert-Eaton una sinapticopatía presináptica

dc.contributor.authorGuerrero Figueroa, Robertospa
dc.date.accessioned2010-01-15 00:00:00
dc.date.available2010-01-15 00:00:00
dc.date.issued2010-01-15
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.32997/rcb-2010-2741
dc.identifier.eissn2389-7252
dc.identifier.issn2215-7840
dc.identifier.urihttps://hdl.handle.net/11227/12913
dc.identifier.urlhttps://doi.org/10.32997/rcb-2010-2741
dc.language.isospaspa
dc.publisherUniversidad de Cartagenaspa
dc.relation.bitstreamhttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2741/2292
dc.relation.citationeditionNúm. 1 , Año 2010spa
dc.relation.citationendpage135
dc.relation.citationissue1spa
dc.relation.citationstartpage128
dc.relation.citationvolume1spa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.relation.referencesWillis T. two discourses concerning the soul of brutes de anima pordage s. (Trans), London 1683.spa
dc.relation.referencesLambert EH. Defects of neuromuscular transmission in syndromes other than myasthenia gravis. Ann NY acad 1959; 135:367-370/.spa
dc.relation.referencesLambert EH. Eaton LM, Rooke ED. Defect or neuromuscular conduction associated with malignant neoplasma. Am j Physiol 1956; 187:612-613.spa
dc.relation.referencesChanguex Jp. The acetylcholine receptor: its molecular biology and biotechnological prospects. BioEssays 1989; 10:48-54.spa
dc.relation.referencesGuerrero-Figueroa R. síndrome de Lambert-Eaton una alteración funcional presináptica. A propósito de tres observaciones. Medicas UIS 1988; 2: 165-171.spa
dc.relation.referencesElmqvist D, Lambert EH. Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo clin proc 1968; 43: 689-713.spa
dc.relation.referencesVicent A, Lang B, Newsom-Davis J. autoimmunity to the voltage gated ca2+ channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci 1989; 12: 496-502.spa
dc.relation.referencesLambert EH, Elmqvist D. Quantal components of end-plate potentials in the myasthenic syndrome. Ann NY Acad Sci 1971; 183: 183-199.spa
dc.relation.referencesHewett Sj, Atchison WD. specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels. Brain Res 1992; 599: 324-332.spa
dc.relation.referencesLang B, Newsom-Davis J, Wray D, et al. Autoimmune etiology for myasthenic (Eaton-Lambert) syndrome. Lancet 1981; 2: 224-226.spa
dc.relation.referencesLang B, Newsom-Davis J, Prior C, et al. antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse. J Physiol 7983; 344:335-345.spa
dc.relation.referencesLeveque c, hoshito t, David P, et al. the synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert Eaton myasthenic syndrome antigen. Proc Natl Acad sci USA 1992; 89:3625-3629spa
dc.relation.referencesLeveque C, El Far O, Martin-Moutot N, et al. purification of the N-type calcium channel associated with syntaxin and synaptotagmin. J Biol chem. 1994; 269: 6306-6312.spa
dc.relation.referencesDavid P, El Far O, El Far O, Martin-Moutot N, et al. expression of synaptotagmin and syntaxin associated with N-type calcium channels in small cell lung cancer. FEBS Lett 993; 326: 135- 139.spa
dc.relation.referencesEl Far O, Marqueze B, Leveque Ch, et al. Antiges associated with N-and L-type calcium channelsd in Lambert-Eaton myasthenic syndrome J Neurichemy 1995; 64: 1969-11702.spa
dc.relation.referencesHajela RK, Atchison WD. Synaptotagmin and syntaxin are not primary target of Lambert Eaton myasthenic syndrome autoantibodies. (Abstr.) Biophys J 1994; 66: A3800.spa
dc.relation.referencesHajela RK, Atchison WD. The proteins synaptotagmin and syntaxin are not general targets of Lambert -Eaton myasthenic syndrome autoantibody. J Neurochem 1995; 64 1245-1251.spa
dc.relation.referencesMartin-Moutot N, Lang B, Newson-Davis J, et al. binding of Lambert-Eaton myasthenic syndrome igC to synaptosomal proteins does not correlate with an inhibition of calcium uptake. Neuroscience letters 1995; 187:115-118.spa
dc.relation.referencesGrassi C, Magnelli V, Carabelli V, et al. inhibition of low-and high-thereshold Ca2+ channels of human neuroblastoma IMR32 cells by Lambert-Eaton myasthenic syndrome (LEMS) igGs. Neuroscience letters 1994; 11181:50-56.spa
dc.relation.referencesBlandino JKW, Viglione MP, Bradley WA, et al. Voltage-dependent sodium channels in human small-cell lung cáncer cells: Role in action potentials and inhibition by Lambert-Eaton syndrome igG. J Membrane boil 1995; 143: 153-163.spa
dc.relation.referencesLennon VA, kryzer TJ, Griesmann GE, et al. calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995; 332: 1467.1474.spa
dc.rightsRevista Ciencias Biomédicas - 2020spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2741spa
dc.subjectSíndrome de Lambert-Eatonspa
dc.subjectcanales de calciospa
dc.subjectreceptores presinápticosspa
dc.subjectspa
dc.titleEl síndrome de Lambert-Eaton una sinapticopatía presinápticaspa
dc.title.translatedEl síndrome de Lambert-Eaton una sinapticopatía presinápticaeng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Archivos

Datos de Contacto

Imagen Escudo Universidad de Cartagena

 

 

 

Línea de Atención

Línea Anticorrupción

Síguenos en: